Massare; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Massare; Michael.The latest application filed is for "recombinant nanoparticle rsv f vaccine for respiratory syncytial virus".

Company Profile

0.6.10

Massare; Michael - Gaithersburg MD
Massare; Michael - Mt. Airy MD
Massare; Michael - Mount Airy MD US
Massare; Michael - Rockville MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods Grant 10,751,410 - Smith , et al. A	2020-08-25
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20170319682 - SMITH; Gale ; et al.	2017-11-09
Highly efficient influenza matrix (M1) proteins Grant 9,464,276 - Smith , et al. October 11, 2	2016-10-11
IMMUNOGENIC MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) COMPOSITIONS AND METHODS App 20160206729 - SMITH; Gale ; et al.	2016-07-21
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20150335730 - SMITH; Gale ; et al.	2015-11-26
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20150306207 - SMITH; Gale ; et al.	2015-10-29
Highly Efficient Influenza Matrix (m1) Proteins App 20150307849 - SMITH; Gale ; et al.	2015-10-29
Highly efficient influenza matrix (M1) proteins Grant 8,992,939 - Smith , et al. March 31, 2	2015-03-31
Modified RSV F proteins and methods of their use Grant 8,715,692 - Pushko , et al. May 6, 2	2014-05-06
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20130122032 - SMITH; Gale ; et al.	2013-05-16
Highly Efficient Influenza Matrix (m1) Proteins App 20130039938 - SMITH; Gale ; et al.	2013-02-14
Modified Rsv F Proteins And Methods Of Their Use App 20100239617 - PUSHKO; Peter ; et al.	2010-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.